REGENXBIO

REGENXBIO is a clinical-stage biotechnology company headquartered in Rockville, MD, focused on developing gene therapy treatments using its proprietary NAV Technology Platform. The company seeks to improve lives through the curative potential of gene therapy across a range of serious diseases.